JP6945479B2 - 分析物濃度を決定する方法 - Google Patents
分析物濃度を決定する方法 Download PDFInfo
- Publication number
- JP6945479B2 JP6945479B2 JP2018040151A JP2018040151A JP6945479B2 JP 6945479 B2 JP6945479 B2 JP 6945479B2 JP 2018040151 A JP2018040151 A JP 2018040151A JP 2018040151 A JP2018040151 A JP 2018040151A JP 6945479 B2 JP6945479 B2 JP 6945479B2
- Authority
- JP
- Japan
- Prior art keywords
- signal
- sample
- reference signal
- measurement
- sensor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000012491 analyte Substances 0.000 title claims description 43
- 238000005259 measurement Methods 0.000 claims description 108
- 238000000034 method Methods 0.000 claims description 67
- 239000012088 reference solution Substances 0.000 claims description 31
- 230000002159 abnormal effect Effects 0.000 claims description 23
- 239000000243 solution Substances 0.000 claims description 20
- 230000007547 defect Effects 0.000 claims description 9
- 230000009471 action Effects 0.000 claims description 8
- 238000013024 troubleshooting Methods 0.000 claims description 7
- 238000004458 analytical method Methods 0.000 claims description 5
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 2
- 229910001424 calcium ion Inorganic materials 0.000 claims description 2
- 150000002500 ions Chemical group 0.000 claims description 2
- 229910001414 potassium ion Inorganic materials 0.000 claims description 2
- 229910001415 sodium ion Inorganic materials 0.000 claims description 2
- 241000208340 Araliaceae Species 0.000 claims 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims 1
- 235000003140 Panax quinquefolius Nutrition 0.000 claims 1
- 235000008434 ginseng Nutrition 0.000 claims 1
- 239000000523 sample Substances 0.000 description 159
- 238000003908 quality control method Methods 0.000 description 36
- 238000012360 testing method Methods 0.000 description 18
- 101100537098 Mus musculus Alyref gene Proteins 0.000 description 14
- 101150095908 apex1 gene Proteins 0.000 description 14
- 239000012530 fluid Substances 0.000 description 12
- 101100269674 Mus musculus Alyref2 gene Proteins 0.000 description 11
- 238000000338 in vitro Methods 0.000 description 11
- 239000003792 electrolyte Substances 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 230000003287 optical effect Effects 0.000 description 7
- 108010054147 Hemoglobins Proteins 0.000 description 6
- 102000001554 Hemoglobins Human genes 0.000 description 6
- 239000000460 chlorine Substances 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 230000002547 anomalous effect Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 229910052754 neon Inorganic materials 0.000 description 3
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical group [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 3
- -1 separate Substances 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 239000012482 calibration solution Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000003918 potentiometric titration Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000013074 reference sample Substances 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 108010003320 Carboxyhemoglobin Proteins 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010061951 Methemoglobin Proteins 0.000 description 1
- 108010064719 Oxyhemoglobins Proteins 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000003914 blood derivative Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 238000004313 potentiometry Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/333—Ion-selective electrodes or membranes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3274—Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/4163—Systems checking the operation of, or calibrating, the measuring apparatus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/417—Systems using cells, i.e. more than one cell and probes with solid electrolytes
- G01N27/4175—Calibrating or checking the analyser
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Description
Claims (15)
- センサによって、試料中の分析物の濃度を決定する方法であって、前記方法は測定された分析物についての試料信号を分析することを含み、
前記試料信号が正常である場合、すなわち、前記試料信号の測定開始時点の信号を基準とした相対値のそれぞれが同一符号である場合には、前記方法は、前記試料信号を、前記分析物の濃度を決定するための前記試料の測定の前に測定された参照溶液の第1参照信号と比較することを含み、
前記試料信号が異常である場合、すなわち、前記試料信号の測定開始時点の信号を基準とした相対値のそれぞれの少なくとも一部が反対符号である場合には、前記方法は、前記試料信号を、前記第1参照信号と前記試料の測定の後に測定された同一の前記参照溶液の第2参照信号との内挿によって計算された参照信号点と比較することを含む方法。 - 前記参照溶液がスタンバイ溶液である、請求項1記載の方法。
- 前記第1参照信号が、前記第1参照信号の最後の利用可能な測定点または前記第1参照信号の予測点である、請求項1または2に記載の方法。
- 前記第2参照信号が前記第2参照信号の最初の利用可能な測定点である、請求項1〜3のいずれか1項に記載の方法。
- 前記試料信号が、前記試料信号の最後の利用可能な測定点または前記試料信号の予測点である、請求項1〜4のいずれか1項に記載の方法。
- 参照信号の測定開始時点の信号を基準とした相対値のそれぞれが同一符号である場合に前記参照信号は正常であり、前記参照信号の測定開始時点の信号を基準とした相対値のそれぞれの少なくとも一部が反対符号である場合に前記参照信号は異常である、請求項1〜5のいずれか1項に記載の方法。
- 前記センサがイオン選択電極センサであって前記試料信号は電位差測定信号である、請求項1〜6のいずれか1項に記載の方法。
- 前記分析物がプロトン、塩化物イオン、ナトリウムイオン、カリウムイオン、カルシウムイオンのいずれかである、請求項1〜7のいずれか1項に記載の方法。
- 連続した試料測定で前記試料信号が繰り返して異常である場合にセンサエラーを示すことを含む、請求項1〜8のいずれか1項に記載の方法。
- 前記試料がQC試料で、前記試料信号、前記第1参照信号、および前記第2参照信号が正常であってQC不良が発生した場合に、前記QC試料の測定の繰り返しおよび/またはセンサエラー以外のエラーを示すことを含む、請求項1〜9のいずれか1項に記載の方法。
- 前記試料信号、前記第1参照信号、および前記第2参照信号のいずれか一つまたは複数が異常であって前記QC不良が所定の回数発生した場合に、センサエラーを示すことを含む、請求項10に記載の方法。
- 前記試料がキャリブレーターであって、前記試料信号、前記第1参照信号、および前記第2参照信号が正常であって校正不良が発生した場合に、前記キャリブレーターの測定を繰り返す、および/または、センサエラー以外のエラーを示すことを含む、請求項1〜11のいずれか1項に記載の方法。
- 前記試料信号、前記第1参照信号、および前記第2参照信号のいずれか一つまたは複数が異常であって前記校正不良が所定の回数発生した場合に、センサエラーを示すことを含む、請求項12に記載の方法。
- 任意の信号および/または任意のエラーを、分析装置のデータベースおよび/またはトラブルシューティングレポートに記録することを含む、請求項1〜13のいずれか1項に記載の方法。
- 装置および/またはセンサの性能の監視のため、および/または、装置および/またはセンサの性能を向上させるデータ分析のため、および/または、サービスまたはトラブルシューティングの促進のため、および/または、修正アクションまたは他のタイプのアクションを遠隔からトリガーするために、ひとつまたは複数のローカルの分析装置から任意の信号および/または任意のエラーを遠隔サーバーまたはクラウドへ送信および収集することを含む、請求項1〜14のいずれか1項に記載の方法。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17159681.0A EP3373004B1 (en) | 2017-03-07 | 2017-03-07 | Method of determining an analyte concentration |
| EP17159681.0 | 2017-03-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018146586A JP2018146586A (ja) | 2018-09-20 |
| JP6945479B2 true JP6945479B2 (ja) | 2021-10-06 |
Family
ID=58401340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018040151A Active JP6945479B2 (ja) | 2017-03-07 | 2018-03-06 | 分析物濃度を決定する方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10877053B2 (ja) |
| EP (1) | EP3373004B1 (ja) |
| JP (1) | JP6945479B2 (ja) |
| CN (1) | CN108572250B (ja) |
| ES (1) | ES2772751T3 (ja) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12320771B2 (en) | 2019-06-12 | 2025-06-03 | Siemens Healthcare Diagnostics Inc. | System and method of measurement and calibration of analyte testing |
| DE102019118171A1 (de) * | 2019-07-04 | 2021-01-07 | Endress+Hauser Conducta Gmbh+Co. Kg | Verfahren zum Betreiben eines automatischen Analysegeräts und ein automatisches Analysegerät |
| JP7173354B2 (ja) * | 2019-08-01 | 2022-11-16 | 株式会社村田製作所 | 検出装置、検出方法およびプログラム |
| US11416825B2 (en) * | 2019-11-01 | 2022-08-16 | Microsoft Technology Licensing, Llc | Managed rooms backbone |
| EP4002041B1 (en) * | 2020-11-19 | 2023-04-12 | Endress+Hauser Group Services AG | Method of predictive monitoring of a variable of a medium and of a measurement accuracy of a measurement device measuring this variable |
| US12601704B2 (en) * | 2023-08-25 | 2026-04-14 | Analog Devices International Unlimited Company | System and method for measurement of ion concentration in fluid samples |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55112546A (en) * | 1979-02-23 | 1980-08-30 | Hitachi Ltd | Atomic extinction analysis meter |
| JPS60168057U (ja) * | 1984-04-13 | 1985-11-07 | 株式会社日立製作所 | 電解質自動分析装置 |
| JPS63231256A (ja) * | 1987-03-19 | 1988-09-27 | Jeol Ltd | イオン選択性電極を用いた検体電解質測定の校正デ−タ処理法 |
| US5112455A (en) * | 1990-07-20 | 1992-05-12 | I Stat Corporation | Method for analytically utilizing microfabricated sensors during wet-up |
| US5204264A (en) * | 1991-03-14 | 1993-04-20 | E. I. Du Pont De Nemours And Company | Method for validation of calibration standards in an automatic chemical analyzer |
| JPH06102240A (ja) * | 1991-11-25 | 1994-04-15 | Tokuyama Soda Co Ltd | イオン濃度測定装置の運転方法 |
| JPH0643133A (ja) * | 1992-07-23 | 1994-02-18 | Toshiba Corp | 生化学分析装置 |
| US20030044318A1 (en) | 2001-09-05 | 2003-03-06 | Lorin Olson | Devices for analyte concentration determination and methods of using the same |
| AU2003296492A1 (en) * | 2002-12-11 | 2004-06-30 | Instrumentation Laboratory Company | Multi-analyte reference solutions |
| JP2004219352A (ja) * | 2003-01-17 | 2004-08-05 | Toshiba Corp | 分析装置及び管理システム |
| CN101583872A (zh) * | 2006-09-14 | 2009-11-18 | 通用电气健康护理生物科学股份公司 | 测定待分析物浓度的方法 |
| WO2008033073A1 (en) | 2006-09-14 | 2008-03-20 | Ge Healthcare Bio-Sciences Ab | A method of determining analyte concentration |
| EP1906178A1 (en) * | 2006-09-26 | 2008-04-02 | F.Hoffmann-La Roche Ag | Method for detecting erroneous measurement results obtained with ion-selective electrodes |
| CN101430387B (zh) * | 2007-11-06 | 2011-05-04 | 核工业北京地质研究院 | 基于土壤气态水的纳米级铀微粒探测方法 |
| GB2457660A (en) * | 2008-02-19 | 2009-08-26 | Sphere Medical Ltd | Methods of calibrating a sensor in a patient monitoring system |
| EP4218571B1 (en) * | 2012-03-16 | 2025-07-30 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
| CN103900938B (zh) * | 2014-04-18 | 2016-01-27 | 淮海工学院 | 一种分离海底沉积物再悬浮过程中悬沙浓度的方法 |
| CA2900201C (en) * | 2014-08-25 | 2025-01-07 | Bio-Rad Laboratories, Inc. | VALUE ASSIGNMENT TO CUSTOMIZABLE QUALITY CONTROLS |
-
2017
- 2017-03-07 ES ES17159681T patent/ES2772751T3/es active Active
- 2017-03-07 EP EP17159681.0A patent/EP3373004B1/en active Active
-
2018
- 2018-03-05 US US15/911,948 patent/US10877053B2/en active Active
- 2018-03-05 CN CN201810179344.1A patent/CN108572250B/zh active Active
- 2018-03-06 JP JP2018040151A patent/JP6945479B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20180259543A1 (en) | 2018-09-13 |
| JP2018146586A (ja) | 2018-09-20 |
| ES2772751T3 (es) | 2020-07-08 |
| EP3373004A1 (en) | 2018-09-12 |
| EP3373004B1 (en) | 2019-12-11 |
| CN108572250A (zh) | 2018-09-25 |
| CN108572250B (zh) | 2021-08-24 |
| US10877053B2 (en) | 2020-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6945479B2 (ja) | 分析物濃度を決定する方法 | |
| EP2428802B1 (en) | Automatic analysis device and analysis method | |
| US20210318266A1 (en) | Electrolyte concentration measurement device | |
| US11002749B2 (en) | Calibration method | |
| US20090222213A1 (en) | Automatic analyzer | |
| KR100321508B1 (ko) | 혈전증및울혈과관련한분석을자동으로실시하는방법및계기 | |
| US9080972B2 (en) | Automatic analyzer | |
| CA2603685A1 (en) | Method for detecting erroneous measurement results obtained with ion selective electrodes | |
| US11226328B2 (en) | Method of detecting the presence or absence of a clot in a liquid sample analyzer | |
| CN107636452B (zh) | 改进的生物传感器系统分析物测量 | |
| US20190011429A1 (en) | Method of detecting presence or absence of a clot in a liquid sample analyzer | |
| CN118425277B (zh) | 电解质分析仪定标故障处理方法及系统 | |
| CN115053126B (zh) | 电解质分析装置 | |
| WO2022146570A1 (en) | Simultaneous and selective washing and detection in ion selective electrode analyzers | |
| Westgard et al. | Validation of iQM active process control technology | |
| CN117554303B (zh) | 液体检测方法、装置、设备及存储介质 | |
| EP2458389A1 (en) | Detection of incorrect placement of liquid containers | |
| JP7716511B2 (ja) | 医用分析装置デバイスの保守を促進するための方法および装置 | |
| US20240125727A1 (en) | Electrochemical measurement with additional reference measurement | |
| US20230009309A1 (en) | Diagnostic analyzers and quality control methods | |
| US20250199020A1 (en) | Calibration management of an in-vitro diagnostic system | |
| US7807041B2 (en) | Method for detecting the presence or absence of a gas bubble in an aqueous liquid | |
| Niculescu | Optical method for improving the accuracy of biochemical assays | |
| CN117825471A (zh) | 样本分析仪及其控制方法 | |
| Westgard et al. | Control Technology |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200319 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20210129 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210209 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210506 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210907 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210914 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6945479 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |